212 related articles for article (PubMed ID: 18931513)
1. Interaction between angiotensin II, osteoprotegerin, and peroxisome proliferator-activated receptor-gamma in abdominal aortic aneurysm.
Moran CS; Cullen B; Campbell JH; Golledge J
J Vasc Res; 2009; 46(3):209-17. PubMed ID: 18931513
[TBL] [Abstract][Full Text] [Related]
2. Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolipoprotein E-knockout mouse.
Moran CS; Jose RJ; Biros E; Golledge J
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2609-16. PubMed ID: 25301844
[TBL] [Abstract][Full Text] [Related]
3. Association of osteoprotegerin with human abdominal aortic aneurysm progression.
Moran CS; McCann M; Karan M; Norman P; Ketheesan N; Golledge J
Circulation; 2005 Jun; 111(23):3119-25. PubMed ID: 15939823
[TBL] [Abstract][Full Text] [Related]
4. The effects of angiotensin II on the coupled microstructural and biomechanical response of C57BL/6 mouse aorta.
Haskett D; Speicher E; Fouts M; Larson D; Azhar M; Utzinger U; Vande Geest J
J Biomech; 2012 Mar; 45(5):772-9. PubMed ID: 22196971
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm.
Deng GG; Martin-McNulty B; Sukovich DA; Freay A; Halks-Miller M; Thinnes T; Loskutoff DJ; Carmeliet P; Dole WP; Wang YX
Circ Res; 2003 Mar; 92(5):510-7. PubMed ID: 12600880
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II Type 1 Receptor Blocker Prevents Abdominal Aortic Aneurysm Progression in Osteoprotegerin-Deficient Mice via Upregulation of Angiotensin (1-7).
Karasaki K; Kokubo H; Bumdelger B; Kaji N; Sakai C; Ishida M; Yoshizumi M
J Am Heart Assoc; 2023 Feb; 12(3):e027589. PubMed ID: 36718875
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.
Manning MW; Cassis LA; Daugherty A
Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):483-8. PubMed ID: 12615694
[TBL] [Abstract][Full Text] [Related]
8. PPARδ reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice by regulating extracellular matrix homeostasis and inflammatory responses.
Hwang JS; Kim HJ; Kim G; Kang ES; Ham SA; Yoo T; Paek KS; Yabe-Nishimura C; Kim HJ; Seo HG
Int J Cardiol; 2014 Jun; 174(1):43-50. PubMed ID: 24698256
[TBL] [Abstract][Full Text] [Related]
9. Disruption of Osteoprotegerin has complex effects on medial destruction and adventitial fibrosis during mouse abdominal aortic aneurysm formation.
Bumdelger B; Otani M; Karasaki K; Sakai C; Ishida M; Kokubo H; Yoshizumi M
PLoS One; 2020; 15(7):e0235553. PubMed ID: 32614927
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone reduces the development and rupture of experimental aortic aneurysms.
Jones A; Deb R; Torsney E; Howe F; Dunkley M; Gnaneswaran Y; Gaze D; Nasr H; Loftus IM; Thompson MM; Cockerill GW
Circulation; 2009 Jun; 119(24):3125-32. PubMed ID: 19506106
[TBL] [Abstract][Full Text] [Related]
11. High serum thrombospondin-1 concentration is associated with slower abdominal aortic aneurysm growth and deficiency of thrombospondin-1 promotes angiotensin II induced aortic aneurysm in mice.
Krishna SM; Seto SW; Jose R; Li J; Moxon J; Clancy P; Crossman DJ; Norman P; Emeto TI; Golledge J
Clin Sci (Lond); 2017 Jun; 131(12):1261-1281. PubMed ID: 28364044
[TBL] [Abstract][Full Text] [Related]
12. Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes.
Pang W; Li N; Ai D; Niu XL; Guan YF; Zhu Y
Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):358-64. PubMed ID: 21291492
[TBL] [Abstract][Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells.
Fu M; Zhang J; Lin Yg Yg; Zhu X; Willson TM; Chen YE
Biochem Biophys Res Commun; 2002 Jun; 294(3):597-601. PubMed ID: 12056809
[TBL] [Abstract][Full Text] [Related]
14. Orchidectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E-deficient mice.
Henriques TA; Huang J; D'Souza SS; Daugherty A; Cassis LA
Endocrinology; 2004 Aug; 145(8):3866-72. PubMed ID: 15105380
[TBL] [Abstract][Full Text] [Related]
15. Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during Angiotensin II induced aneurysm formation.
Eagleton MJ; Ballard N; Lynch E; Srivastava SD; Upchurch GR; Stanley JC
J Surg Res; 2006 Oct; 135(2):345-51. PubMed ID: 16716358
[TBL] [Abstract][Full Text] [Related]
16. Relaxin and Matrix Metalloproteinase-9 in Angiotensin II-Induced Abdominal Aortic Aneurysms.
Howatt DA; Dajee M; Xie X; Moorleghen J; Rateri DL; Balakrishnan A; Da Cunha V; Johns DG; Gutstein DE; Daugherty A; Lu H
Circ J; 2017 May; 81(6):888-890. PubMed ID: 28420827
[TBL] [Abstract][Full Text] [Related]
17. Osteoprotegerin is associated with aneurysm diameter and proteolysis in abdominal aortic aneurysm disease.
Koole D; Hurks R; Schoneveld A; Vink A; Golledge J; Moran CS; de Kleijn DP; van Herwaarden JA; de Vries JP; Laman JD; Huizinga R; Pasterkamp G; Moll FL
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1497-504. PubMed ID: 22516062
[TBL] [Abstract][Full Text] [Related]
18. Pravastatin activates activator protein 2 alpha to augment the angiotensin II-induced abdominal aortic aneurysms.
Ma H; Liang WJ; Shan MR; Wang XQ; Zhou SN; Chen Y; Guo T; Li P; Yu HY; Liu C; Yin YL; Wang YL; Dong B; Pang XY; Wang SX
Oncotarget; 2017 Feb; 8(9):14294-14305. PubMed ID: 28179583
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse.
Moran CS; Rush CM; Dougan T; Jose RJ; Biros E; Norman PE; Gera L; Golledge J
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):898-907. PubMed ID: 26966276
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in mice.
Qian HS; Gu JM; Liu P; Kauser K; Halks-Miller M; Vergona R; Sullivan ME; Dole WP; Deng GG
Gene Ther; 2008 Feb; 15(3):224-32. PubMed ID: 18033310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
